Results for transaminasestigninger translation from Danish to English

i de kliniske studier med pegasys ved hbv har markante transaminasestigninger været ledsaget af lette ændringer i andre mål for leverfunktionen og uden evidens for hepatisk dekompensation.
in clinical trials with pegasys in hbv, marked transaminase flares have been accompanied by mild changes in other measures of hepatic function and without evidence of hepatic decompensation.

50 stigninger i serum-alat.i de kliniske studier med pegasys ved hbv har markante transaminasestigninger været ledsaget af lette ændringer i andre mål for leverfunktionen og uden evidens for hepatisk dekompensation.
in clinical trials with pegasys in hbv, marked transaminase flares have been accompanied by mild changes in other measures of hepatic function and without evidence of hepatic decompensation.

forhøjede billirubin og hepatiske transaminaserværdier: for grad 3-4 bilirubin- og transaminasestigninger, skal dosis reduceres til 400 mg 1 gang dagligt eller seponeres.
elevated bilirubin and hepatic transaminases: for grade 3-4 bilirubin and hepatic transaminase elevations, doses should be reduced to 400 mg once daily or interrupted.

i ca. halvdelen af de tilfælde, hvor stigningen oversteg 10 gange øvre referencegrænse, blev pegasys- dosis reduceret eller seponeret, indtil transaminasestigningerne var forsvundet, hvorimod behandlingen fortsatte uændret i de resterende tilfælde.
in approximately half the case of flares exceeding 10 times the upper limit of normal, pegasys dosing was reduced or withheld until the transaminase elevations subsided, while in the rest therapy was continued unchanged.